Alsadhan, Norah
Alhurishi, Sultana A
Pujades-Rodriguez, Mar
Shuweihdi, Farag
Brennan, Cathy
West, Robert M
Funding for this research was provided by:
This study is part of Norah Alsadhan's PhD study, funded by King Saud University, Riyadh, Kingdom of Saudi Arabia.
Article History
Received: 12 December 2023
Accepted: 16 April 2024
First Online: 26 April 2024
Declarations
:
: This study was approved by the Research Ethics Committee of the School of Medicine at the University of Leeds (MREC 19–069) and by the Ethics Committee of King Saud University (E-20-4644) and was performed in accordance with the Declaration of Helsinki. The Research Ethics Review Committees of the University of Leeds and King Saud University waived the need for informed consent due to the retrospective and anonymous study design.
: Not applicable.
: The authors declare no competing interests. MPR is currently employed by UCB Biopharma.